| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $7,949,377 ) |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R56AI180204 | Transcriptional Regulation of the Il13 Gene in Mast Cells | 000 | 1 | NIH | 1/4/2024 | $226,775 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08ES034820 | Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | 000 | 2 | NIH | 12/5/2023 | $174,528 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 001 | 3 | NIH | 1/29/2024 | $896,399 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL157424 | Proteolysis in the Pathogenesis of ARDS | 000 | 3 | NIH | 11/6/2023 | $622,291 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01ES033678 | Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease | 000 | 3 | NIH | 11/29/2023 | $646,640 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL155894 | Interstitial macrophages in cigarette smoke-induced small airway remodeling | 000 | 3 | NIH | 12/27/2023 | $158,328 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 000 | 4 | NIH | 4/11/2024 | $409,019 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 4 | NIH | 2/20/2024 | $485,411 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 000 | 4 | NIH | 2/22/2024 | $369,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 000 | 1 | NIH | 3/4/2024 | $610,880 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 1 | NIH | 12/6/2023 | $116,126 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 000 | 5 | NIH | 3/14/2024 | $329,638 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 3/1/2024 | $187,525 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 3/1/2024 | $421,206 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 001 | 7 | NIH | 1/29/2024 | $855,492 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL122995 | Asthma susceptibility due to environmental programming of innate immunity in utero | 000 | 10 | NIH | 12/1/2023 | $543,336 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 12 | NIH | 2/27/2024 | $653,847 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 000 | 2 | NIH | 3/4/2024 | $621,982 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R13HL174110 | Aspen Lung Conference Pulmonary Fibrosis - focusing on the future | 000 | 1 | NIH | 3/27/2024 | $30,000 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | CE152490 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 2/29/2024 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | CE152490 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | CE152490 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | CE152490 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 12/1/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 000 | 2 | NIH | 10/30/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 000 | 4 | NIH | 12/23/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 04 | 21 | HRSA | 12/5/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 03 | 21 | HRSA | 11/6/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL141770 | Mannose binding lectin-dependent complement activation in emphysema | 000 | 5 | NIH | 4/8/2024 | -$42,259 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01ES029430 | Optimization of AEOL10150 treatment of sulfur mustard-induced lung toxidrome in a pig model | 000 | 5 | NIH | 12/8/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 000 | 6 | NIH | 11/28/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI130780 | National Jewish Health CoFAR Clinical Research Unit | 000 | 7 | NIH | 12/13/2023 | $0 |
| | 2024 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL166828 | Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema | 000 | 1 | NIH | 1/8/2024 | $0 |
| | 2024 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R13HL164036 | Aspen Lung Conference: Bridging the Gap between Innate and Adaptive Immunity in the Lung | 000 | 1 | NIH | 12/19/2023 | -$2,343 |
| | 2024 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R13HL164036 | Aspen Lung Conference: Bridging the Gap between Innate and Adaptive Immunity in the Lung | 000 | 1 | NIH | 12/19/2023 | -$234 |
| | 2024 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21ES032951 | Repurposing thiosulfate for chlorine gas exposure | 000 | 2 | NIH | 10/23/2023 | $0 |
| | 2024 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL146228 | Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria | 000 | 4 | NIH | 4/9/2024 | -$35,789 |
| | 2024 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141146 | Selenocyanate as a novel treatment of cystic fibrosis lung disease | 000 | 4 | NIH | 4/8/2024 | -$728 |
| | 2024 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL136786 | Modulating macrophage-mediated Inflammation in cystic fibrosis | 000 | 6 | NIH | 1/22/2024 | -$2,092 |
| | 2024 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R56AG073317 | Loss of progenitor function accelerates lung aging | 000 | 1 | NIH | 2/22/2024 | $0 |
| | 2024 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21AR076553 | The Anti-Cyclic Citrullinated Protein Antibody Repertoire and Lung Involvement in Rheumatoid Arthritis | 000 | 2 | NIH | 11/8/2023 | $0 |
| | 2024 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL144396 | Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma | 000 | 4 | NIH | 4/9/2024 | $0 |
| | 2024 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL140357 | Epigenetic Regulation of Immune Pathways in Sarcoidosis | 000 | 4 | NIH | 1/29/2024 | $0 |
| | 2024 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL136681 | A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis | 000 | 4 | NIH | 12/6/2023 | -$12,070 |
| | 2024 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL140595 | Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis | 000 | 4 | NIH | 10/23/2023 | $0 |
| | 2024 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01HL089897 | (1 of 2) Genetic Epidemiology of COPD | 000 | 15 | NIH | 2/16/2024 | $0 |
| | 2024 | 2019 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL126125 | The Breathewell Program to Improve Asthma Outcomes | 001 | 5 | NIH | 10/19/2023 | -$46,291 |
| | 2024 | 2019 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL126125 | The Breathewell Program to Improve Asthma Outcomes | 000 | 5 | NIH | 10/1/2023 | -$267,239 |
|
| Issue Date FY: 2023 ( Subtotal = $30,435,488 ) (Continued on the next page) |
| | 2023 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL141770 | Mannose binding lectin-dependent complement activation in emphysema | 001 | 5 | NIH | 6/9/2023 | $0 |
|
